Recent Quotes
My Watchlist
Indicators
Markets
Stocks
Funds
Overview
Currencies
International
Treasuries

Articles published by Enigma Biomedical USA, Inc.

Enigma Biomedical USA announces FDA Acceptance of New Drug Application for florquinitau F-18 (MK-6240), a Tau PET Alzheimer’s Disease radiodiagnostic
From Enigma Biomedical USA, Inc.
Via Business Wire
Enigma Biomedical USA, Inc. Announces a Collaboration to Apply Novel 4R PET Imaging Biomarkers to CTE Research
From Enigma Biomedical USA, Inc.
Via Business Wire
Enigma Biomedical USA, Inc. Announces Candidate Selection of Novel 4R Tau PET Imaging Biomarkers
From Enigma Biomedical USA, Inc.
Via Business Wire
Neuraly and Enigma Biomedical USA announce a Research License and Commercialization Option Agreement for PET Imaging Biomarker, PMI04
From Enigma Biomedical USA, Inc.
Via Business Wire
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.